0001140361-20-013627.txt : 20200611
0001140361-20-013627.hdr.sgml : 20200611
20200611202423
ACCESSION NUMBER: 0001140361-20-013627
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200611
FILED AS OF DATE: 20200611
DATE AS OF CHANGE: 20200611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ELI LILLY & Co
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39321
FILM NUMBER: 20958563
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
FORMER NAME:
FORMER CONFORMED NAME: LILLY ELI & CO
DATE OF NAME CHANGE: 19941024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avidity Biosciences, Inc.
CENTRAL INDEX KEY: 0001599901
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461336960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10975 N. TORREY PINES RD.,
STREET 2: #150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-401-7900
MAIL ADDRESS:
STREET 1: 10975 N. TORREY PINES RD.,
STREET 2: #150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity Biosciences LLC
DATE OF NAME CHANGE: 20161227
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity NanoMedicines LLC
DATE OF NAME CHANGE: 20140211
3
1
form3.xml
FORM 3
X0206
3
2020-06-11
0
0001599901
Avidity Biosciences, Inc.
RNA
0000059478
ELI LILLY & Co
LILLY CORPORATE CENTER
DROP CODE 1094
INDIANAPOLIS
IN
46285
true
Series C Preferred Stock
0
Common Stock
4576342
D
Shares of Series C Preferred Stock are convertible at any time, at the holder's election, at a ratio of one-for-2.1095 shares of the Issuer's Common Stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series C Preferred Stock will automatically convert at a ratio of one-for-2.1095 shares of the Issuer's Common Stock. The Series C Preferred Stock has no expiration date.
ELI LILLY AND COMPANY /s/ Bronwen Mantlo Name: Bronwen Mantlo Title: Vice President, Deputy General Counsel and Corporate Secretary ** Signature of Reporting Person
2020-06-11